Bisphosphonates Flashcards

1
Q

what are the two types of bisphosphonates?

A
  1. non nitrogen containing
  2. nitrogen containing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

name some non-nitrogen containing and nitrogen containing bisphosphonates?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe the two classifications of bisphosphonates

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the mechanism of action for bisphosphonates

A

inhibit HMG-CoA
inhibiting osteoclasts = inhibiting bone resorption
=bind strongly onto the bone (up to 10 years)

they also inhibit formation and dissolution of hydroxyapatite crystals = potential to interfere with bone mineralisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

compare the activity of two types of bisphosphonates?

A
  1. Non-nitrogen BP (etidronate, clodronate)
    * Mimic pyrophosphate
    * Accumulate in osteoclasts to cause cell death
  2. Nitrogen containing BP – more potent antiresorptive
    * Interfere with specific metabolic reactions
    * Inhibit mevalonate biosynthesis pathway,
    * Main target farnesyl pyrophosphate synthase (FPPS) important in production
    of signalling proteins for osteoclast activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe the PK of BP’s?

A

Poor oral absorption
* Alendronate, risedronate F= 0.7%
* Etidronate F=6%
* Oral absorption reduced
- Excreted unchanged in urine = no metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

why do BP’s have a reduced oral absorption?

A

this is due to food increasing gastric emptying
particularly calcium containing products or polyvalent cations = decrease the efficacy of BP’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the clinical indications for BP’s?

A
  1. Prevention and treatment of osteoporosis
  2. Hypercalcaemia of malignancy
  3. Bone damage due to metastatic cancer and bone pain 4. Paget’s disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the overall aims of BP’s?

A

increase bone mineral density
= reduce fracture risk
-vetebral/non-veterbral/hip fractures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the conditions you must meet as a patient to take BP’s for osteoporosis?

A
  1. eligible under NICE recommended guidance for osteoporosis
  2. fracture score is at least 1%
    • determined by FRAX score/ BMD with DXA/ Fracture score
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are symptoms of malignancy?

A

Skeletal (pain, fracture)
Neuromuscular and psychiatric (drowsiness, muscle weakness, impaired concentration/ memory) Gastrointestinal (nausea, anorexia, constipation)
Renal (renal colic, thirst)
Cardiovascular – (arrhythmia, shortened QT interval)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how does malignancy cause hypercalcemia?

A

malignancy = increase bone turnover = increase calcium release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are symptoms of hypercalcemia?

A

confusion
nausea
Anorexia
impaired concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what BPs are licensed to treat hypercalemia?

A

IV zoledronic
IV pamidronate
with IV fluids
effective within 24 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what monitoring is required for BPs to treat hypercalemia?

A

Check renal function (adjust dose if necessary),
- renally excreted
* Check calcium at 5 to 7 days be careful of hypocalcemia

HYPOCALCEMIA with those with amino glycoside antibiotics toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what BPs are licensed to treat osteoporosis?

A

Aledronic acid
Ibandronic acid
Risedronate
Zoledronic acid

16
Q

what is Paget disease?

A
17
Q

what are the adverse effects of BPs?

A

Osteonecrosis of the jaw (ONJ) - dentist must be aware when commencing and undergo regular check ups
Osteonecrosis of external auditory canal - v rare
Oesophageal ulceration
oesophageal risks
Atypical femoral fractures -rarely reported

18
Q

which BPs are most at risk of osteonecrosis of the jaw?

A

Risk highest for IV (zoledronate, pamidronate) use in cancer and for higher potency bisphosphonates (zoledronate)

19
Q

when must you review BP treatment?

A

after 5 years:
alendronic acid
risedronate sodium
ibandronic acid

after 3 years:
zolendronic acid

20
Q

what are the oesophageal risks associated with BPs? therefore consoling points you may consider

A

Oesophagitis
Oesophageal ulcers
Oesophageal strictures
Oesophageal erosions

minimise formulation getting stuck to the oesophagus

reinforce with 200mL of water and sit up right